ESC 365 - Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

ESC Premium Access

Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Session: Oral anticoagulants : news from large trials and registries

Topic: Anticoagulants

Speaker: Doctor H. Jeong (Iksan, KR)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Hyung Ki Jeong

Wonkwang University Hospital, Iksan (Korea (Republic of))

0 follower

5 more presentations in this session

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Speaker: Doctor R. Amiya (Osaka, JP)

Characterization of major and clinically relevant non-major bleeding in the APEX trial

Speaker: Miss M. Yee (Boston, US)

Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Speaker: Doctor M. Lamberts (Copenhagen, DK)

Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Speaker: Mr J. Strange (Copenhagen, DK)

Access the full session

Oral anticoagulants : news from large trials and registries

Speakers: Doctor H. Jeong, Doctor R. Amiya, Miss M. Yee, Doctor M. Lamberts, Doctor M. Proietti...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources